Two Pediatric Methadone Fatalities: Case Reports from the Office of the Medical Examiner Phoenix, Arizona

Size: px
Start display at page:

Download "Two Pediatric Methadone Fatalities: Case Reports from the Office of the Medical Examiner Phoenix, Arizona"

Transcription

1 Two Pediatric Methadone Fatalities: Case Reports from the Office of the Medical Examiner Phoenix, Arizona Kim McCall Tackett, BS; Amy Lais, BS; Diane Mertens Maxham, BS; Vladimir Shvarts, MD; and Norman A. Wade, MS Methadone Synthetic Opioid Synthesized during WW II by German Scientists (morphine 1803) Clinically available in US in 1947 Used for treatment of narcotic addictions (early 1970 s) Later used for treatment of chronic pain

2 Methadone Prior use and cellular tolerance significant when evaluating blood concentrations Fatal concentrations vary greatly Overlapping therapeutic and lethal ranges Little information about incidence and associated toxicity in pediatrics Methadone Emphasis Comparison with morphine: Much longer duration of action Stereochemistry: Used as a racemic mixture Variability: In both pharmacokinetics and pharmacodynamics Adverse effects: Respiratory depression and ventricular arrhythmias (?) Caution: In initiation or alteration of therapy Structure of Methadone Pharmacokinetics A Oral Availability: 92% Plasma protein binding: 89% Clearance: 2.3 ml/min/kg Volume of distribution: 3.6 L/kg Elimination half-life: 27 (15-40 hr) (5-130 hr): similar for the stereoisomers Peak effect ~ 1 hr sc or im; 4 hr po Dosing interval after first dose may be shorter due to redistribution than after chronic (accumulation)

3 Pharmacokinetics B Urinary excretion about 24%, (10-35%) and depends on ph because of ion trapping in acid urine Up to 90% can be eliminated by hepatic biotransformation P450 N-demethylation followed by cyclization to pyrrolidines and pyrroline Other metabolites CYP3A4, CYP2C8 and CYP2D6 all participate in the stereoselective oxidative metabolism Drug Interactions Barbiturates, carbamazepine, efavirenz (NNRTI), nevirapine (induction of CYP3A4), phenytoin and rifampin accelerate metabolism of methadone and can precipitate withdrawal symptoms Fluvoxamine (SSRI) decreases metabolism of methadone and can lead to methadone toxicity Potential methadone toxicity: Ketoconazole (CYP3A4 selective inhibitor) Trimethoprim (CYP2C8 selective inhibitor) Paroxetine (CYP2D6, CYP3A4, CYP2C8 inhibitor) Accumulation With repeated doses steady-state plasma drug concentrations are reached in about 4 times the elimination half-life For methadone that usually takes hours (3-7 days); also same for excretion Impaired metabolism by liver disease, inhibition of CYP enzymes, and/or genetically slower metabolism may give accumulation time of 520 hours (22 days)

4 Pharmacodynamics Stereoisomers: d(s) and l(r) racemic mixture The analgesic activity of the racemic mixture is almost entirely the result of the content of levo - methadone, which is 8-50 times more potent than the d-isomer D-methadone also lacks significant respiratory depressant action and addiction liability but does have possess antitussive activity Mu Opioid Receptor Methadone (l) is an agonist at this receptor G protein linked Located in the respiratory control areas of pons (rate of respiration) and medulla (rhythm, drive/force, integration, chemoreception) of the brain Activated by exogenous/endogenous opioids Blocked by Naloxone Respiratory Depression Potassium Channel Opioids increase conductance by increasing the flow of K ions which hyperpolarizes neurons so they will not fire Adenyl Cyclase Inhibition by opioids decreases camp Chloride Channel Opioids have no effect here but others do e.g. Benzodiazepines, Propofol and Phenobarbital increase conductance Increase in Methadone Rxs Change in Rx pattern for chronic pain Less rigid regulatory environment for providers Changing knowledge basis Physiology of pain Molecular biology of nociception Applied pharmacology in pain Rx Cost and the 3 rd party payers!!!!

5 Methadone Death Investigations Decedent Hx Rx and illicit drug abuse Signs/Symptoms euphoria, slurred speech, ataxia,unable to arouse, snoring, coma, death Pathology pulmonary and cerebral edema Scene Markers drug paraphernalia; Rxs Interacting Factors Pharmacologic Low or lost opioid tolerance Slower or altered opioid metabolism Drug interactions (e.g. benzodiazepines) Time of death in relation to ingestion Postmortem Acute, rapid death vs. delayed death Postmortem redistribution Mechanism of Death Methadone produces hypoventilation, sleep-disordered breathing and sleep apnea even in stable MMT patients Effect of benzodiazepines were not related to postmortem concentrations low levels result in relaxation of respiratory muscles potentially leading to obstruction Occlusion of airway is more likely in slow developing cumulative toxicity of the drug

6 Why People Die Suicide by a 12 Year Old Moderate to high doses of drug not tolerated well in opioids naïve patients Prior experience with opioids (tolerance) cannot protect one from the adverse effects of methadone (CNS depression) Co-ingestion of ethanol and other CNS depressant drugs leads to synergism Other factors include long half-life, etc. Case # 1 12 y.o. female found unresponsive in bedroom by family Suicide history; self mutilations EMS summoned Resuscitation efforts unsuccessful Death pronounced at scene Frothy purge noted from mouth Autopsy Performed 55 hours after death 120 lb./ 65 inches - Caucasian Female Lungs congested: Left 500g, Right 510g Cerebral edema: Brain 1350g Heart wt: 250g Liver: 1000g Spleen: 200g Kidneys: 120 g Gastric: 150 ml brown semisolid fluid

7 Specimens Collected Pleural Fluid Bile Vitreous Fluid Gastric Contents Liver Spleen Brain Analytical Protocol Volatile screen on vitreous and pleural fluid by GC-FID Positive ethanol ELISA screen on pleural fluid Negative Qualitative analysis for basic drugs on pleural fluid and bile Positive Methadone Analyzed by GC-NPD and GC/MS Only Methadone and low ethanol found Quantitated by GC-NPD / 5 point calibration Levels in Pediatric Suicide Murder? of a Five Year Old Pleural fluid 0.7 mg/l Ethanol 0.07 g% Brain mg/kg Spleen g/kg Liver mg/kg Gastric mg/kg 16.7 mg total

8 Case #2 Five year old male Caucasian child 43 inches tall, 44 pounds = normal Treated for Autism (??) Rx for Risperdal Living alone with father (mother deceased) Hx of fever and congestion & ear infection Apparently snoring / raspy breathing Specimens Collected Cardiac Blood Bile Gastric Urine Vitreous CSF Lung Tissue Culture Swabs Autopsy Findings Externally no injuries or trauma Heart 108 gm and normal Lungs 164 / 212 gm & well expanded Spleen/thymus/ lymphatic all normal GI all normal with 75 ml brown/red PDF 729 gm liver and pancreas normal Kidneys 63 / 46 gm grossly normal Brain 1650 gm no hemorrhages/fractures Levels in Pediatric Homocide Cardiac blood Methadone 0.34 mg/l EDDP metabolite Dextromethorphan 0.24 mg/l Doxylamine 0.36 mg/l Acetaminophen 69 mg/l Risperidone < mg/l 9-Hydroxyrisperidone mg/l

9 Levels in Five Year Old Bile Gastric Methadone 0.63 mg/l Methadone 23.8 mg/l (1.8 mg total) EDDP metabolite Dextromethorphan Doxylamine Levels Continued Urine Methadone 8.36 mg/l EDDP metabolite EMDP metabolite Dextromethorphan Doxylamine Doxylamine metabolite Borate 7 mg/l by NMS Methadone Lethal Levels Segal/Catherman (1974) Robinson & William (1971) Manning et al. (1976) Garriott/Sterner (1973) Drummer (1992) Clark et al. (1995) Li et al. Karch 2000 (2000) mg/l mg/l mg/l mg/l mg/l mg/l mg/l mg/l Ther. Drug Monitoring, Vol 24, No. 4, K. Woolf Phoenix OME Hx Levels Phoenix OME Hx Levels Lowest Levels in Blood Average mg/l Highest Levels in Blood Range mg/l (mean 3.0 mg/l) Methadone is a lipophilic organic base known to concentrate to a considerable extent in solid organs, thus providing a gradient for passive diffusion after death. This uneven distribution of methadone might account for some but not all of the differences in blood concentrations reported at autopsy Karch

10 Conclusions Cause of death Drug overdose for both cases Manner of death Suicide (12 y/o); Undetermined (5 y/o) Homocide or Accident by father Levels found versus historical data indicate a clear finding of lethal levels 0.70 mg/l and 0.36 mg/l in blood References SOFT Methadone Workshop 2003 G. D. Olsen, M.D. Bruce A. Goldberger, Ph.D. David Moody, Ph.D. Kim Woolf, Ph.D. Randall Baselt, Ph.D. Red Book

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA Pharmacogenetics of Codeine Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA 1 Codeine Overview Naturally occurring opium alkaloid Demethylated to morphine for analgesic effect

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

FORENSIC SCIENCE NEWSLETTER Forensic Pathology and Neuropathology. William A. Cox, M.D., FCAP.

FORENSIC SCIENCE NEWSLETTER Forensic Pathology and Neuropathology. William A. Cox, M.D., FCAP. FORENSIC PATHOLOGY FORENSIC SCIENCE NEWSLETTER Forensic Pathology and Neuropathology William A. Cox, M.D., FCAP www.forensicjournals.com June 1, 2016 The Safety of Newborn Infants who are Breast Fed by

More information

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr.D.Raju,M.pharm, Lecturer Mechanisms of Pain and Nociception Nociception is the mechanism whereby noxious peripheral stimuli are transmitted to

More information

Methadone Maintenance

Methadone Maintenance Methadone Maintenance A Practical Guide to Pharmacotherapy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Ron Joe, MD, DABAM Objectives I. Pharmacology Of Methadone II. Practical Application of Pharmacology

More information

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms: Opioid Overdose Best Practices Guideline Table of Contents A. General description B. Typical signs and symptoms C. Expected course D. Making the diagnosis E. Recommended treatment F. Criteria for hospital

More information

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO OST Pharmacology & Therapeutics Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO Disclaimer In the past two years I have received no payment for services from any agency other than government or academic.

More information

Sedative-Hypnotics. Sedative Agents (General Considerations)

Sedative-Hypnotics. Sedative Agents (General Considerations) Sedative Agents (General Considerations) No best sedative agent Any agent given in sufficient dosage can produce any level of sedation Intravenous dosing is more predictable then intramuscular or oral

More information

PARACOD Tablets (Paracetamol + Codeine phosphate)

PARACOD Tablets (Paracetamol + Codeine phosphate) Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s

More information

What Can Dead People Tell Us? Postmortem Toxicology for Attorneys

What Can Dead People Tell Us? Postmortem Toxicology for Attorneys What Can Dead People Tell Us? Postmortem Toxicology for Attorneys Dr. Allison A. Muller Diplomate, American Board of Applied Toxicology Principal/Owner: Acri Muller Consulting, LLC Learning objectives

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

An Introduction to Forensic Toxicology

An Introduction to Forensic Toxicology An Introduction to Forensic Toxicology Jennifer Shea, PhD, FCACB Ken Obenson, MBBS MFFLM (UK) FRCPC (Anat) FRCPC (Forensic Path) Dip American Brd of Path (Anat & Clin/Cytopath/Forensic Path) April 11,

More information

ANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017

ANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017 Ky Stoltzfus, MD Assistant Professor, Internal Medicine University of Kansas Medical Center ANSWER # 1 Your response might be

More information

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008

More information

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1) Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,

More information

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, )

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, ) All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy (Paraclesus, 1493-1541) Discussion Questions About Paraclesus Quote 1. Do you agree

More information

Opioid Review and MAT Clinic Comorbidities Associated with Opioid Overdose

Opioid Review and MAT Clinic Comorbidities Associated with Opioid Overdose 1 Opioid Review and MAT Clinic Comorbidities Associated with Opioid Overdose March 7, 2018 Learning Objectives Differentiate the medical diagnoses that increase the risk of taking opioids Identify the

More information

Relapsing Late in Life: Opioid use disorder in a geriatric patient

Relapsing Late in Life: Opioid use disorder in a geriatric patient Relapsing Late in Life: Opioid use disorder in a geriatric patient Kerry Sheets, MD Geriatric Medicine Fellow, HCMC MAGIC Annual Conference, 11/9/2018 Outline Case presentation Epidemiology of opioid use/misuse

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Mike Frontz, Robert Rodriguez, Gary Kunsman Bexar County Medical Examiner s Office, San Antonio, TX Brad Hall, Patricia Schroeder,

More information

Original Research Article Actual and Potential Drug Interactions Associated with Methadone

Original Research Article Actual and Potential Drug Interactions Associated with Methadone Blackwell Publishing IncMalden, USAPMEPain Medicine1526-23752007 Blackwell Publishing Ltd? 200793315344Review Article Actual and Potential Drug Interactions Associated with MethadoneWeschules et al. PAIN

More information

Probuphine. (buprenorphine implant) New Product Slideshow

Probuphine. (buprenorphine implant) New Product Slideshow Probuphine (buprenorphine implant) New Product Slideshow Introduction Brand name: Probuphine Generic name: Buprenorphine Pharmacological class: Opioid (partial agonist-antagonist) Strength and Formulation:

More information

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist What is the difference between pharmacokinetics and pharmacodynamics? Definitions Pharmacokinetics = what the body does

More information

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates OPIOID PHARMACOLOGY PCTH 300/305 Andrew Horne, PhD andrew.horne@ubc.ca MEDC 309 THE OPIUM POPPY Papaver somniferum Sleep-bringing poppy Poppy Seeds Opiates Opium Poppy Straw 1 OPIATES VS. OPIOIDS Opiates:

More information

Principles of Toxicology: The Study of Poisons

Principles of Toxicology: The Study of Poisons Principles of Toxicology: The Study of Poisons Elizabeth Casarez Department of Pharmacology and Toxicology University it of Arizona The study of the adverse effects of a toxicant on living organisms Adverse

More information

Cytochrome P450 Drug Interaction Table Flockhart Table

Cytochrome P450 Drug Interaction Table Flockhart Table Cytochrome P450 Drug Interaction Table Flockhart Table The table contains lists of drugs in columns under the designation of specific cytochrome P450 isoforms. CYTOCHROME P450 DRUG INTERACTION TABLE A

More information

Opioids: Effects on Human Performance and Behavior

Opioids: Effects on Human Performance and Behavior Opioids: Effects on Human Performance and Behavior Peter R. Stout Aegis Sciences Corp. Nashville TN Laurel J. Farrell Colorado Bureau of Investigation Opioids Used to refer to a group of drugs that are

More information

Substance Misuse and Abuse

Substance Misuse and Abuse CHAPTER 18 Substance Misuse and Abuse Lesson Objectives 1. Explain actions that can be taken to help prevent youth from abusing drugs and other substances. 2. Describe specific steps for preventing someone

More information

Each tablet contains:

Each tablet contains: Composition: Each tablet contains: Tolvaptan 15/30mg Pharmacokinetic properties: In healthy subjects the pharmacokinetics of tolvaptan after single doses of up to 480 mg and multiple doses up to 300 mg

More information

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY TRAPADOL INJECTION FOR I.V./I.M. USE ONLY Composition : Each 2ml. contains : Tramadol Hydrochloride I.P. Water for injection I.P. 100mg. q.s. CLINICAL PHARMACOLOGY : Pharmacodynamics Tramadol is a centrally

More information

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming

More information

Composition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:

Composition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties: Composition: Each tablet contain Montelukast Levocetirizine 10mg 5mg Each 5ml contains Montelukast Levocetirizine 4mg 2.5mg Pharmacokinetic properties: Peak plasma concentrations of montelukast are achieved

More information

EDUCATIONAL COMMENTARY METHADONE

EDUCATIONAL COMMENTARY METHADONE EDUCATIONAL COMMENTARY METHADONE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing Education

More information

Principles of Pharmacology. Pharmacokinetics & Pharmacodynamics. Mr. D.Raju, M.pharm, Lecturer PHL-358-PHARMACOLOGY AND THERAPEUTICS-I

Principles of Pharmacology. Pharmacokinetics & Pharmacodynamics. Mr. D.Raju, M.pharm, Lecturer PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Principles of Pharmacology Pharmacokinetics & Pharmacodynamics PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr. D.Raju, M.pharm, Lecturer Pharmacokinetics Movement of drugs in the body Four Processes Absorption

More information

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW Introduction Brand name: Dsuvia Generic name: Sufentanil Pharmacological class: Opioid agonist Strength and Formulation: 30mcg; sublingual tabs (housed in a disposable,

More information

Tranquilizers & Sedative-Hypnotics

Tranquilizers & Sedative-Hypnotics Tranquilizers & Sedative-Hypnotics 1 Tranquilizer or anxiolytic: Drugs used therapeutically to treat agitation or anxiety Sedative-Hypnotic: drugs used to sedate and aid in sleep Original sedatives (before

More information

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani Drugs Used In Management Of Pain Dr. Aliah Alshanwani 1 Drugs Used In Management Of Pain A CASE OF OVERDOSE Sigmund Freud, the father of psychoanalysis His cancer of the jaw was causing him increasingly

More information

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation

More information

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes Salicylate (Aspirin) Ingestion California Poison Control 1-800-876-4766 Background 1. The prevalence of aspirin-containing analgesic products makes these agents, found in virtually every household, common

More information

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR) PHARMKIN WORKSHOP A PHARMACOKINETICS TEACHING SIMULATION Joseph K. Ritter, Ph.D. Associate Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@mail2.vcu.edu Tompkins-McCaw Libray Room 2-006

More information

Optimizing Opioid Dependence Treatment A Guideline for Pharmacists

Optimizing Opioid Dependence Treatment A Guideline for Pharmacists Optimizing Opioid Dependence Treatment A Guideline for Pharmacists Module 3: Optimal Use of Methadone F e b r u a r y 2 0 1 5 Learning Objectives To know and understand the pathophysiology of substance

More information

Index. E Elderly. See also Older patients analgesic efficacy and opioid adverse effects, 280

Index. E Elderly. See also Older patients analgesic efficacy and opioid adverse effects, 280 A Acute pain, methadone maintained patients, 33 Addiction antisocial behaviors, 24 definition, 15 Drug Addiction Treatment Act 2000, 140 heroin, 41 morphine, 91 opioid, 16 related counseling, 23 treatment

More information

General Anesthesia. Mohamed A. Yaseen

General Anesthesia. Mohamed A. Yaseen General Anesthesia Mohamed A. Yaseen M.S,c Surgery Before Anesthesia General Anesthesia ( GA ) Drug induced absence of perception of all sensation allowing surgery or other painful procedure to be carried

More information

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the normal processing of fear vs fear processing

More information

Buprenorphine as a Treatment Option for Opioid Use Disorder

Buprenorphine as a Treatment Option for Opioid Use Disorder Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital

More information

Methadone was synthesized by German chemists during Wold War II when cut off their opium supply. It is difficult to fight a war without analgesics,

Methadone was synthesized by German chemists during Wold War II when cut off their opium supply. It is difficult to fight a war without analgesics, Methadone was synthesized by German chemists during Wold War II when cut off their opium supply. It is difficult to fight a war without analgesics, Germans went to work and synthesized a number of medications

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET 1. PRODUCT NAME (strength pharmaceutical form) Methatabs, Tablet, 5 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substance Methadone hydrochloride BP 5 mg Excipient(s)

More information

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction

More information

Fluids. There are 32 body fluids that may be found at a crime scene

Fluids. There are 32 body fluids that may be found at a crime scene Fluids& Toxicology Fluids There are 32 body fluids that may be found at a crime scene Some of them include amniotic fluid, bile, cerebrospinal fluid, mucus, perspiration, phlegm, saliva, semen, tears,

More information

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY Administration of Naloxone for Opiate Overdose Disclaimer: Authorization - EMT Optional Skills Only authorized Emergency Medical Technicians (EMT) who

More information

Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans

Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics 7/9/2012 Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA

More information

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects

More information

Bupivacaine Overdose Following Genital Injection. Sarah Kerrigan, Ph.D. Bureau Chief New Mexico Dept. Health Scientific Laboratory Division

Bupivacaine Overdose Following Genital Injection. Sarah Kerrigan, Ph.D. Bureau Chief New Mexico Dept. Health Scientific Laboratory Division Bupivacaine Overdose Following Genital Injection Sarah Kerrigan, Ph.D. Bureau Chief New Mexico Dept. Health Scientific Laboratory Division History of Local Anesthetics First clinical operation under anesthesia

More information

Pharmacokinetics for Physicians. Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne

Pharmacokinetics for Physicians. Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne Pharmacokinetics for Physicians Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne The Important Therapeutic Questions What drug? What dose? How long? Drug Dosage

More information

To Dream The Impossible Dream: Acute Pain Management for Patients on Buprenorphine

To Dream The Impossible Dream: Acute Pain Management for Patients on Buprenorphine To Dream The Impossible Dream: Acute Pain Management for Patients on Buprenorphine Tanya J. Uritsky, PharmD, BCPS, CPE Disclosure Nothing to disclose 1 Learning Objectives Describe how the pharmacokinetic

More information

B. Long-acting/Extended-release Opioids

B. Long-acting/Extended-release Opioids 4 Opioid tolerance is assumed in patients already taking fentanyl 25 mcg/hr OR daily doses of the following oral agents for 1 week: 60 mg oral morphine, 30 mg oxycodone, 8 mg hydromorphone, 25 mg of oxymorphone

More information

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes

More information

Antidepressants and Sedatives. David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School

Antidepressants and Sedatives. David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School Antidepressants and Sedatives David G. Standaert, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School Depression A frequent problem, affecting up to 5% of the population Common presentations

More information

Module Two: Pharmacotherapies for Opioid Substitution Treatment

Module Two: Pharmacotherapies for Opioid Substitution Treatment Module Two: Pharmacotherapies for Opioid Substitution Treatment Neurobiology of Addiction Pharmacology of Opioids Methadone Buprenorphine Pharmacokinetics of Methadone & Buprenorphine Opioid effects Intoxication

More information

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE DR. SHILPA ADARKAR ASSOCIATE PROFESSOR DEPARTMENT OF PSYCHIATRY & DRUG DEADDICTION CENTRE OF EXCELLENCE SETH GSMC & KEMH LONG TERM OPTIONS FULL AGONIST PARTIAL

More information

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description

More information

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight Drug Profile of Dicyclomine Generic Name Dicyclomine IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure Molecular Weight 309.48 Molecular formula C 19 H 35 NO 2 Melting

More information

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

Opioid Analgesics. Recommended starting dose for opioid-naïve patients Opioid Analgesics Goals: Restrict use of opioid analgesics to OHP-funded conditions with documented sustained improvement in pain and function and with routine monitoring for opioid misuse and abuse. Promote

More information

Chapter 25. General Anesthetics

Chapter 25. General Anesthetics Chapter 25 1. Introduction General anesthetics: 1. Analgesia 2. Amnesia 3. Loss of consciousness 4. Inhibition of sensory and autonomic reflexes 5. Skeletal muscle relaxation An ideal anesthetic: 1. A

More information

Comedy of Errors: Methadone and Buprenorphine

Comedy of Errors: Methadone and Buprenorphine Comedy of Errors: Methadone and Buprenorphine Douglas Gourlay MD, MSc, FRCP(C), DFASAM Disclosures Nothing to disclosure 2 1 Learning Objectives Explain the pharmacology of methadone and buprenorphine

More information

Buprenorphine pharmacology

Buprenorphine pharmacology Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely

More information

Appendix D: Drug Tables

Appendix D: Drug Tables Appendix D: Drug Tables A. Short-acting, Orally Administered Opioids Table D-1: Use of Short-acting, Orally Administered Opioids in Adults [198] Additional Maximum APAP dose: 4000 mg/d (2000 mg/d in chronic

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

DBL NALOXONE HYDROCHLORIDE INJECTION USP

DBL NALOXONE HYDROCHLORIDE INJECTION USP Name of medicine Naloxone hydrochloride Data Sheet New Zealand DBL NALXNE HYDRCHLRIDE INJECTIN USP Presentation DBL Naloxone Hydrochloride Injection USP is a sterile, clear, colourless solution, free from

More information

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology

Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology Objective: To discuss basic principles of psychopharmacology in children and adolescents. Pharmacokinetics:

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR: M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered

More information

XTRAM. Composition Xtram 50 mg capsule Each capsule contains Tramadol HCl 50 mg

XTRAM. Composition Xtram 50 mg capsule Each capsule contains Tramadol HCl 50 mg XTRAM Composition Xtram 50 mg capsule Each capsule contains Tramadol HCl 50 mg Capsules Action Tramadol is a centrally acting synthetic analgesic of the aminocyclohexanol group with opioid-like effects.

More information

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS) Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS) Georgios Dadoudis Anesthesiologist ICU DIRECTOR INTERBALKAN MEDICAL CENTER Optimal performance requires:

More information

Industrial Toxicology

Industrial Toxicology Industrial Toxicology Learning Objectives Know the assumptions of the doseresponse and time-course curves Be able to define and label key points of a curve Know the difference between potency and efficacy

More information

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. Course Outline Introduction and Overview

More information

Dr. Hiwa K. Saaed. PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Analgesic

Dr. Hiwa K. Saaed. PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Analgesic 12/17/18 Analgesics Opioids" Pharmacology Dr. Hiwa K. Saaed PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani 2018-2019 1 Analgesic Analgesic an agent that selectively relieves

More information

Basic Pharmacology. Understanding Drug Actions and Reactions

Basic Pharmacology. Understanding Drug Actions and Reactions Basic Pharmacology Understanding Drug Actions and Reactions MARIA A. HERNANDEZ Ph.D. Pharmaceutical and Administrative College of Pharmacy Nova Southeastern University Ft. Lauderdale, Florida, U.S.A. APPU

More information

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE Joseph K. Ritter, Ph.D. Assoc. Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@vcu.edu This self study module will reinforce the

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Page 1 / 6 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Fentadon 50 microgram/ml, solution for injection for dogs SE, DK: Fentadon Vet. 50 microgram/ml, solution for injection

More information

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)

More information

Objectives. Disclosure. Opioid Adverse Effects. Strategies for Monitoring and Reducing Opioid Related Oversedation 7/25/2013

Objectives. Disclosure. Opioid Adverse Effects. Strategies for Monitoring and Reducing Opioid Related Oversedation 7/25/2013 Strategies for Monitoring and Reducing Opioid Related Oversedation Mitchell Nazario, PharmD, CPE Clinical Pain Specialist West Palm Beach VA Medical Center Pharmacy Service (119) 7305 N. Military Trail

More information

Chapter 5. The Actions of Drugs. Origins of Drugs. Names of Drugs. Most drugs come from plants or are chemically derived from plants

Chapter 5. The Actions of Drugs. Origins of Drugs. Names of Drugs. Most drugs come from plants or are chemically derived from plants Chapter 5 The Actions of Drugs Origins of Drugs Most drugs come from plants or are chemically derived from plants Names of Drugs Chemical name: Complete chemical description of the molecule Example: N'-[2-[[5-(dimethylaminomethyl)-2-furyl]

More information

Dr M H Mosaddegh Pharm D, PhD

Dr M H Mosaddegh Pharm D, PhD Dr M H Mosaddegh Pharm D, PhD opioid All compounds related to opium Opium derived from opos, Greek word of juice, juice of opium poppy, Papaver somniferum Opiates Drugs derived from opium. Included the

More information

Benzodiazepines. Benzodiazepines

Benzodiazepines. Benzodiazepines : History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines

More information

PHARMACOKINETIC STUDY OF DEXTROMETHORPHAN WITH URINARY EXCRETION

PHARMACOKINETIC STUDY OF DEXTROMETHORPHAN WITH URINARY EXCRETION PHARMACOKINETIC STUDY OF DEXTROMETHORPHAN WITH URINARY EXCRETION Heesun CHUNG, Wonkyung YANG, Hwakyung CHOI, Wontack JIN, Sihnyoung SIHN, Youngchan YOO National Institute of Scientific Investigation, Seoul,

More information

Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview

Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview Benzodiazepines/Class/Structure Benzodiazepine Metabolism/Elimination Biological Specimens Instrumentation Analytical Method Controls

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore

More information

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN ANTOINETTE BROWN, RPH LAUREL RAMER, 2019 PHARMD CANDIDATE 2018 WYOMING CONFERENCE ON AGING LARAMIE, WY OCTOBER 3, 2018 OBJECTIVES 1. Understand the

More information

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Naloxone Statewide Standing Order Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Objectives Review the US & NC trends on opioid overdose Understand key

More information

OPIOID IR COMBO DRUGS. Oxycodone-acetaminophen, Oxycodone-aspirin, Oxycodone-ibuprofen, Tramadolacetaminophen

OPIOID IR COMBO DRUGS. Oxycodone-acetaminophen, Oxycodone-aspirin, Oxycodone-ibuprofen, Tramadolacetaminophen RATIONALE FOR INCLUSION IN PA PROGRAM Background Apadaz (benzhydrocodone-acetaminophen), codeine-acetaminophen, dihydrocodeine-caffeineacetaminophen, hydrocodone-acetaminophen, hydrocodone-ibuprofen, oxycodoneacetaminophen,

More information

Pharmacotherapy Issues in the Pediatric Population

Pharmacotherapy Issues in the Pediatric Population Pharmacotherapy Issues in the Pediatric Population Continuing Professional Pharmacy Development Dr. Shane Pawluk, PharmD Dr. Andrea Cartwright, PharmD Dr. Maryam Khaja March 26, 2014 Outline Didactic Session

More information

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and

More information

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 1 2 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 3 4 5 6 Course Outline Introduction

More information

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition Naloxone: Preventing Opioid Overdose in the Community Sharon Stancliff, MD Medical Director Harm Reduction Coalition DISCLOSURES Sharon Stancliff MD has nothing to disclose LEARNING OBJECTIVES 1. Discuss

More information